These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8510217)

  • 1. Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells.
    Nair S; Babu JS; Dunham RG; Kanda P; Burke RL; Rouse BT
    J Virol; 1993 Jul; 67(7):4062-9. PubMed ID: 8510217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation.
    Babu JS; Nair S; Kanda P; Rouse BT
    Vaccine; 1995 Dec; 13(17):1669-76. PubMed ID: 8719518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
    Vasilakos JP; Michael JG
    J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins.
    Rouse RJ; Nair SK; Lydy SL; Bowen JC; Rouse BT
    J Virol; 1994 Sep; 68(9):5685-9. PubMed ID: 8057449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro.
    Nair S; Zhou F; Reddy R; Huang L; Rouse BT
    J Exp Med; 1992 Feb; 175(2):609-12. PubMed ID: 1531064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens.
    Wijburg OL; van den Dobbelsteen GP; Vadolas J; Sanders A; Strugnell RA; van Rooijen N
    Eur J Immunol; 1998 Feb; 28(2):479-87. PubMed ID: 9521056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells.
    Chikh GG; Kong S; Bally MB; Meunier JC; Schutze-Redelmeier MP
    J Immunol; 2001 Dec; 167(11):6462-70. PubMed ID: 11714813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses.
    Nair S; Buiting AM; Rouse RJ; Van Rooijen N; Huang L; Rouse BT
    Int Immunol; 1995 Apr; 7(4):679-88. PubMed ID: 7547695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1.
    Smith CM; Belz GT; Wilson NS; Villadangos JA; Shortman K; Carbone FR; Heath WR
    J Immunol; 2003 May; 170(9):4437-40. PubMed ID: 12707318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
    Porgador A; Gilboa E
    J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.
    Macatonia SE; Patterson S; Knight SC
    Immunology; 1991 Nov; 74(3):399-406. PubMed ID: 1769689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses.
    De Bruijn ML; Nieland JD; Schumacher TN; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1992 Nov; 22(11):3013-20. PubMed ID: 1425925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes.
    Arkema A; Huckriede A; Schoen P; Wilschut J; Daemen T
    Vaccine; 2000 Jan; 18(14):1327-33. PubMed ID: 10618529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs.
    Bungener L; Huckriede A; Wilschut J; Daemen T
    Biosci Rep; 2002 Apr; 22(2):323-38. PubMed ID: 12428908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal delivery of CTL epitopes to dendritic cells.
    Chikh G; Schutze-Redelmeier MP
    Biosci Rep; 2002 Apr; 22(2):339-53. PubMed ID: 12428909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of antigen presentation by dendritic cells and splenic adherent cells in the induction of an allogeneic cytotoxic T-lymphocyte response to H-2Kk liposomes.
    Greenstein JL; Herrmann SH; Sunshine GH; Burakoff SJ
    Cell Immunol; 1986 Jul; 100(2):389-99. PubMed ID: 2944605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.
    Schmidt ST; Olsen CL; Franzyk H; Wørzner K; Korsholm KS; Rades T; Andersen P; Foged C; Christensen D
    Eur J Pharm Biopharm; 2019 Jul; 140():29-39. PubMed ID: 31055066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.